Cross-Border Impact Ventures Exceeds $90 Million in Final Close of Its Women’s and Children’s Health Technology Fund
The Fund also benefits from a guarantee provided by the Swedish International Development Cooperation Agency ( SIDA ).
- The Fund also benefits from a guarantee provided by the Swedish International Development Cooperation Agency ( SIDA ).
- CBIV invests in health technology companies with global growth, high return, and impact potential.
- Its primary focus is on medical device, diagnostic, and digital health companies based in North America and Europe that are globally relevant, including in emerging markets.
- We bring in industry and clinical experts from our international network to unlock growth and impact,” said Donna Parr, Managing Partner at CBIV.